Back to search

National and Kapodistrian University of Athens

Η ανίχνευση μελανοκυττάρων στο περιφερικό αίμα ως δείκτης παρακλούθησης ασθενών με μελάνωμα υψηλού κινδύνου υπό θεραπεία με ιντερφερόνη

Abstract

dc:description

During the last decades the incidence of malignant melanoma steadily increases and the need for markers in detection of early metastasis and guidance of therapy has become urgent. Presence of melanoma cells in peripheral blood could indicate dissemination in the circulation, and thus a high risk of metastasis. For detecting tumor cells in melanoma patients RT-PCR has been used to identify expression of tyrosinase a key enzyme in melanin biosynthesis, in the circulation of melanoma patients. To address the prognostic implications of the presence of circulating melanoma cells we investigated the presence of tyrosinase mRNA by RT-PCR in the peripheral blood of stage IIB and III melanoma patients on high dose adjuvant interferon alpha-2β at multiple sequential time points from initiation of treatment. Total RNA was isolated from the mononuclear cell fraction of peripheral blood, and after reverse transcription, cDNA samples were amplified by nested PCR. Results were confirmed by Southern blotting and hybridization with radiolabeled probe. The sensitivity of the assay was determined by serial dilution of SK-mel28 melanoma cells and was high enough to detect 1 SK-mel28 cell in 10⁷ mononuclear cells, after Southern blotting and autoradiography. Four hundred eighty-eight blood samples from sixty melanoma patients were tested for tyrosinase expression. The correlation between relapse and RT-PCR results was evaluated by the x² test. Relapse-free and overall survival were analysed by the Kaplan-Meir method. Positive RT-PCR result during follow-up was the only prognostic factor that significantly correlated with higher risk of relapse. Our data suggest that circulating melanoma cells are markers of high relapse risk and shorter disease-free survival. Tyrosinase mRNA amplification by RT-PCR may be a useful tool for monitoring the efficacy of adjuvant treatment in stage IIB and III melanoma patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kefala, Georgia
  • Κεφάλα, Γεωργία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/22067

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kefala, Georgia; Κεφάλα, Γεωργία. Η ανίχνευση μελανοκυττάρων στο περιφερικό αίμα ως δείκτης παρακλούθησης ασθενών με μελάνωμα υψηλού κινδύνου υπό θεραπεία με ιντερφερόνη. National and Kapodistrian University of Athens, 2002. http://hdl.handle.net/10442/hedi/22067